PMX Trial “Better than Expected”I would have thought that this disclosure from Dr. Kellum might have been followed up with an updated Investor Presentation or NR by now. It has had no impact on the share price or demand for the stock. Except for a brief TFSA driven run up the SP has been stuck on hold, with declining volume, since the "trial update" was provided.
Not so hard to believe I guess, but still hard to believe.